Search

everythinglearnresearchcommunity

for

Search:↓

A mother's PPARγ is crucial for preventing harmful milk that can cause inflammation and growth problems in babies.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

The Wnt/β-catenin pathway helps tissue regeneration but can also cause fibrosis, and drugs that inhibit this pathway may aid in healing skin and heart tissues.

Wnt signaling helps control how brain stem cells divide and is important for brain repair after injury.

Researchers found a specific immune receptor in patients that causes severe skin reactions to a drug.

Human beard hair medulla contains a unique and complex mix of keratins not found in other human tissues.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

Pregnancy can increase lupus activity, but careful planning and treatment can improve outcomes.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

The genus Sophora has compounds with potential health benefits and could lead to new drugs, but more research is needed to understand their effects and safety.

Certain types of T cells are essential for healthy skin and play a role in skin diseases, but more research is needed to improve treatments.

Stress hormone corticosterone blocks a growth factor to slow down hair stem cell activity and hair growth.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

Mesenchymal stem cells show potential for skin healing and anti-aging, but more research is needed for safe use, especially regarding stem cells from induced pluripotent sources.

Mutations in Gasdermin A3 cause skin inflammation and hair loss by disrupting mitochondria.

Researchers found over 40 compounds in Bituminaria bituminosa, including many flavonoids and some with potential for medical and hair care uses.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

Mice lacking a key DNA methylation enzyme in skin cells have a lower chance of activating stem cells necessary for hair growth, leading to progressive hair loss.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

The nude gene causes skin cell overgrowth and improper development, leading to hair and urinary issues.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Beta-caryophyllene helps improve wound healing in mice, especially in females.

A new protein was made to detect specific skin cell growth receptors and worked in normal skin but not in skin cancer cells.

Alisertib was found to be an effective and tolerable treatment for children with recurrent brain tumors.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

PHBV nanofiber matrices help wounds heal faster when used with hair follicle cells.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

RANK-RANKL signaling is essential for hair growth and skin health.

EdnrB signaling helps melanocyte stem cells regenerate and could be targeted to treat pigmentation issues.

The document concludes that the skin's immune system is complex, involving interactions with hair follicles, nerves, and microbes, and can protect or cause disease, offering targets for new treatments.